Tae‐Hoon Chung
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Histone Deacetylase Inhibitors Research, Lymphoma Diagnosis and Treatment, Ubiquitin and proteasome pathways
Most-Cited Works
- → Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma(2011)277 cited
- → Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression Profiling(2007)257 cited
- → EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphoma(2016)137 cited
- → Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes(2017)119 cited
- → Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis(2018)104 cited
- → Metastasis-associated PRL-3 induces EGFR activation and addiction in cancer cells(2013)85 cited
- → Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS(2022)78 cited
- → IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma(2019)77 cited
- → p53 haploinsufficiency and functional abnormalities in multiple myeloma(2014)77 cited
- → Adrenocortical carcinoma survival rates correlated to genomic copy number variants(2008)77 cited